People who talk in their sleep may be at greater risk of stroke, according to a study of 8,001 Chinese adults. The risk was ...

Semaglutide and liraglutide are associated with a reduced risk for hospitalization due to alcohol use disorder (AUD).

GLP-1RA dispensing has increased from 2022 and 2023, whereas metabolic bariatric surgery has decreased among individuals with obesity.

There may be properties of anti-obesity medications that lead to reduced use. For example, naltrexone decreases cravings for alcohol and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may ...

Insurance business units report positive operating performance while facing mounting industry-wide cost pressures Allegheny Health Network reports 9% total revenue ...

Now that millions of people have used the drugs, several obesity experts told The Associated Press that perhaps 20% of ...

Compared with standard AUD medications, the use of semaglutide and liraglutide was linked to a lower risk for alcohol use ...

The glucose-lowering and weight-reducing drug class appears to benefit the heart and kidneys in people with lupus and lupus nephritis, independently of glucose-lowering and weight loss.

According to CMS estimates, passage of the rule would open access to the weight-loss medications to 3.4 million potential new ...

The popular glucagon-like peptide-1 (GLP-1) receptor agonists known to help in weight loss as well as manage blood sugar can ...

Washington Unlike scores of people who scrambled for the blockbuster drugs Ozempic and Wegovy to lose weight in recent years, ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid ...